Communiqués Ainos, Inc.

Actions

AIMD

US00902F4028

Equipement et technologie médicale avancés

Temps Différé Nasdaq Autres places de cotation 16:13:39 06/07/2026			Varia. 5j.	Varia. 1 janv.
1,900 ^USD	+1,60%		+6,15%	+15,85%

27/05	Les plus fortes baisses de l'avant-bourse	MT
13/05	Ainos, Inc. publie ses résultats pour le premier trimestre clos le 31 mars 2026	CI

Communiqués

22/06	VASRO Research Highlights Ainos' Expansion of Smell AI Into Patient-Level Breath Intelligence	AQ
17/06	Ainos Expands Smell AI Platform into Digital Breath Intelligence Through National Taiwan University Research Program	AQ
08/06	Ainos Releases 2026 Mid-Year CEO Letter to Shareholders	AQ
05/06	VASRO Research Highlights Ainos Smell AI Expansion into Emergency Department Operations	AQ
03/06	Zacks SCR Discusses Ainos' Expansion of Smell AI into Healthcare Infrastructure Through NTUH Study	AQ
01/06	Ainos Launches Smell AI Study at National Taiwan University Hospital for ER Overcrowding and Respiratory Infection Risk Analysis	AQ
20/05	VASRO Research Highlights Ainos AI Nose Commercialization Progress and Semiconductor Industry Shift Toward AI-Driven Environmental Intelligence	AQ
18/05	Zacks Small-Cap Research Highlights Ainos' Smell AI Commercialization	AQ
13/05	Ainos Reports First Quarter 2026 Financial Results and Highlights Smell AI Execution Across Semiconductors and Healthcare Infrastructure Markets	AQ
11/05	Ainos Updates Standard Industrial Classification Code to Reflect Smell AI Business Focus	AQ
17/04	VASRO: Ainos Expands Smell AI from Industrials into Healthcare Infrastructure, Reinforcing AI Infrastructure Positioning and Multi-Vertical Scalability	AQ
08/04	Ainos, MacKay Memorial Hospital and Topco Scientific Partner to Advance Smell AI Deployment in High-Risk Hospital Environments	AQ
01/04	VASRO Research Highlights Ainos' Smell AI Commercial Progress and 2026 Deployment Momentum	AQ
30/03	Ainos Reports Full Year 2025 Financial Results and Highlights Commercial Momentum Entering 2026	AQ
19/03	The Wall Street Journal Highlights Emerging "Smell AI" - Ainos Advances Commercial Deployment in Semiconductor Environments	AQ
12/01	Ainos : Water Tower Research Highlights Ainos SmellTech's Rising Commercial Momentum in Scalable AI Infrastructure Platform Shift	PU
30/06/25	Ainos : Completes Stock Consolidation, Enters New Phase of Global Expansion and Technology Commercialization	PU
23/05/25	Ainos Showcases Breakthrough AI Nose Technology at COMPUTEX 2025 with Japan's Robotics Partner	AQ
12/05/25	Ainos Reports First Quarter 2025 Financial Results	AQ
05/05/25	Atossa Therapeutics and Ainos Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV	AQ
30/04/25	Ainos Forms Partnership with ASE's Key Site to Power AI-Driven SmellTech in Semiconductor Smart Manufacturing	AQ
23/04/25	Water Tower Research Spotlights Ainos' Smell Integration in Humanoid Robot - AI Smelltech is Progressing Rapidly	AQ
21/04/25	Ainos and ugo Complete First Robotic Smell Integration in Japan	AQ
15/04/25	Ainos Secures TFDA Approval and IRB Clearance to Advance VELDONA Clinical Trials for HIV Oral Warts and Sjogren's syndrome in Taiwan	AQ
14/04/25	Ainos Secures TFDA Approval and IRB Clearance to Advance VELDONA Clinical Trials for HIV Oral Warts and Sjögren's Syndrome in Taiwan	AQ